Sofia, Bulgaria – “Sopharma” AD has announced the sale of 1,000 repurchased shares on July 16, 2025. This transaction represents 0.001% of the company’s share capital and was executed at a total value of BGN 2,580.00 on the Bulgarian Stock Exchange. The average price per share was BGN 2.58.
Following this sale, Sopharma’s total number of treasury shares stands at 8,530,383, accounting for 4.75% of its share capital.
Acoziborole Winthrop, a new oral treatment for sleeping sickness developed by the Drugs for Neglected Diseases initiative (DNDi) and Sanofi, has received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for…
The number of votes in AB Volvo has changed following the conversion of 2,000,619 Series A shares into an equal number of Series B shares.
Sanofi and Regeneron have announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Dupixent (dupilumab) for children aged two to 11 years with…
Sign-up for the Weekly Newsletter from EU Business Daily.